Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 1/20 | 0.38 |
| ▸ | PGR | P06401 | 9/20 | 0.36 |
| ▸ | GNG2 | P59768 | 1/20 | 0.34 |
| ▸ | GNB1 | P62873 | 1/20 | 0.34 |
| ▸ | APP | P05067 | 1/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.33 |
| ▸ | MARK3 | P27448 | 1/20 | 0.32 |
| ▸ | PTH1R | Q03431 | 1/20 | 0.32 |
| ▸ | TNK2 | Q07912 | 3/20 | 0.31 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | GFER | P55789 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22891764 | 0.87 | GNG2 (0.45) | PDK2PGRGNG2GNB1APP | |
| SCHEMBL22891670 | 0.85 | ALDH1A1 (0.46) | PDK2PGRGNG2GNB1APP | |
| SCHEMBL22891640 | 0.85 | PDK2 (0.40) | PDK2PGRGNG2GNB1APP | |
| SCHEMBL22891468 | 0.84 | PDK2 (0.43) | PDK2PGRGNG2GNB1APP | |
| SCHEMBL24646447 | 0.83 | PGR (0.37) | PDK2PGRMEN1KMT2A | |
| SCHEMBL14838256 | 0.83 | PGR (0.37) | PDK2PGRMEN1KMT2A | |
| SCHEMBL22891638 | 0.82 | PDK2 (0.40) | PDK2PGRGNG2GNB1APP | |
| SCHEMBL22891510 | 0.82 | PDK2 (0.38) | PDK2PGRAPPTNK2MEN1 | |
| SCHEMBL24027645 | 0.81 | PGR (0.47) | PDK2PGRGNG2GNB1APP | |
| SCHEMBL26574674 | 0.80 | PDK2 (0.48) | PDK2APPMEN1KMT2AGFER |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3764416-B1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO LTD (KR) | 2022-01-26 | — | — | EP | disclosed |
| US-20210013420-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2021-01-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210013420-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME, AND ELECTRONIC DEVICE THEREOF | PIEZO1, ORAI2, OR10J3 | PDK2 2546/4885PGR 2596/4885GNG2 2366/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.